TY -的A2 -施瓦茨,斯蒂芬·金——夏朝,Ning-Yi AU -林,Chun-Ju AU -赖,Chun-Ting AU -拜尔,亨利AU - Chang Cheng-Hsien AU - Lin Jane-Ming盟——蔡Yi-Yu PY - 2021 DA - 2021/02/11 TI - Intravitreal Aflibercept救援治疗视网膜新生血管形成和黄斑水肿疾病由于宝莲寺SP - 8887362六世- 2021 AB -我们报告的救助效果Intravitreal Aflibercept注射对视网膜新生血管形成和黄斑水肿疾病由于宝莲寺。例1是一个36岁的女性。Intravitreal aflibercept管理是抢救治疗后持续的视网膜新生血管形成视网膜光凝术之后,眼周的去炎松,和Intravitreal初注入。视网膜新生血管形成最初退化,但5个月后复发与黄斑水肿。两个intravitreal aflibercept注射,黄斑水肿和视网膜新生血管形成退化。她的视力提高到20/25和43个月后保持稳定。例2是一个27岁的女性。Intravitreal aflibercept后管理持续的视网膜新生血管形成和黄斑水肿后眼周的去炎松注射。最初黄斑水肿消退,但3个月后复发。Intravitreal aflibercept注射进行每三个月维护她的视力20/20。 The patient has been followed up for 28 months. Intravitreal aflibercept was effective as a rescue therapy in the treatment of Eales disease to regress retinal neovascularization, though repeated injections were necessary in cases of recurrence. SN - 2090-6722 UR - https://doi.org/10.1155/2021/8887362 DO - 10.1155/2021/8887362 JF - Case Reports in Ophthalmological Medicine PB - Hindawi KW - ER -